26 related articles for article (PubMed ID: 6657517)
1. A
Shamshirian D; Erfani M; Beiki D; Hajiramazanali M; Fallahi B
Iran J Pharm Res; 2016; 15(3):349-360. PubMed ID: 27980570
[TBL] [Abstract][Full Text] [Related]
2. Cyclic lactam alpha-melanotropin analogues of Ac-Nle4-cyclo[Asp5, D-Phe7,Lys10] alpha-melanocyte-stimulating hormone-(4-10)-NH2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors.
Hruby VJ; Lu D; Sharma SD; Castrucci AL; Kesterson RA; al-Obeidi FA; Hadley ME; Cone RD
J Med Chem; 1995 Sep; 38(18):3454-61. PubMed ID: 7658432
[TBL] [Abstract][Full Text] [Related]
3. [Nle4, D-Phe7]-alpha-MSH: a superpotent melanotropin that "irreversibly" activates melanoma tyrosinase.
Hadley ME; Abdel Malek ZA; Marwan MM; Kreutzfeld KL; Hruby VJ
Endocr Res; 1985; 11(3-4):157-70. PubMed ID: 3009169
[TBL] [Abstract][Full Text] [Related]
4. 4-Norleucine, 7-D-phenylalanine-alpha-melanocyte-stimulating hormone: a highly potent alpha-melanotropin with ultralong biological activity.
Sawyer TK; Sanfilippo PJ; Hruby VJ; Engel MH; Heward CB; Burnett JB; Hadley ME
Proc Natl Acad Sci U S A; 1980 Oct; 77(10):5754-8. PubMed ID: 6777774
[TBL] [Abstract][Full Text] [Related]
5. Prolonged stimulation of S91 melanoma tyrosinase by [Nle4, D-Phe7]-substituted alpha-melanotropins.
Abdel Malek ZA; Kreutzfeld KL; Marwan MM; Hadley ME; Hruby VJ; Wilkes BC
Cancer Res; 1985 Oct; 45(10):4735-40. PubMed ID: 2992767
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of the superagonist [N alpha-chlorotriazinylaminofluorescein-Ser1,Nle4,D-Phe7]-al pha-MSH.
Chaturvedi DN; Hruby VJ; Castrucci AM; Kreutzfeld KL; Hadley ME
J Pharm Sci; 1985 Mar; 74(3):237-40. PubMed ID: 2989482
[TBL] [Abstract][Full Text] [Related]
7. Behavioral effects of [4-norleucine, 7-D-phenylalanine]-alpha-melanocyte-stimulating hormone.
Kobobun K; O'Donohue TL; Handelmann GE; Sawyer TK; Hruby VJ; Hadley ME
Peptides; 1983; 4(5):721-4. PubMed ID: 6657517
[TBL] [Abstract][Full Text] [Related]
8. [Role of alpha-MSH and related peptides in the central nervous system].
Delbende C; Jegou S; Tranchand-Bunel D; Leroux P; Tonon MC; Mocaër E; Pelletier G; Vaudry H
Rev Neurol (Paris); 1985; 141(6-7):429-39. PubMed ID: 2868517
[TBL] [Abstract][Full Text] [Related]
9. [Alpha-melanocyte-stimulating hormone. From bench to bedside].
Böhm M; Luger TA
Hautarzt; 2010 Jun; 61(6):497-504. PubMed ID: 20512306
[TBL] [Abstract][Full Text] [Related]
10. Melanocortins and cardiovascular regulation.
Versteeg DH; Van Bergen P; Adan RA; De Wildt DJ
Eur J Pharmacol; 1998 Oct; 360(1):1-14. PubMed ID: 9845266
[TBL] [Abstract][Full Text] [Related]
11. Behavioral effects of melanocyte stimulating hormone.
LaHoste GJ; Olson GA; Kastin AJ; Olson RD
Neurosci Biobehav Rev; 1980; 4(1):9-16. PubMed ID: 6995875
[No Abstract] [Full Text] [Related]
12. Alpha-melanocyte-stimulating hormone and behavior.
Datta PC; King MG
Neurosci Biobehav Rev; 1982; 6(3):297-310. PubMed ID: 6294567
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]